奥氮平
精神分裂症谱
精神分裂症(面向对象编程)
治疗指标
医学
心理学
精神科
参考范围
精神病
内科学
药品
作者
Katja Wesner,Christoph Hiemke,Niels Bergemann,Karin Egberts,Stefanie Fekete,Manfred Gerlach,Ursula Havemann‐Reinecke,Xenija Lense,Thomas Riemer,Georgios Schoretsanitis,Manfred Uhr,Gerald Zernig,Gerhard Gründer,X.M. Hart
摘要
A therapeutic reference range of 20–40 ng/mL for oral and long-acting injectable olanzapine yields optimal treatment effects in schizophrenia spectrum disorders. Dose reduction is not needed above 40 ng/mL in case of good clinical efficacy and tolerance.
科研通智能强力驱动
Strongly Powered by AbleSci AI